Pharmaceutical lifecycle management : making the most of each and every brand /

A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to m...

Full description

Saved in:
Bibliographic Details
Main Author: Ellery, Tony
Other Authors: Hansen, Neal
Format: Electronic eBook
Language:English
Published: Hoboken, N.J. : John Wiley & Sons, ©2012.
Subjects:
Online Access:CONNECT

MARC

LEADER 00000nam a2200000 a 4500
001 in00006108913
006 m o d
007 cr cn|||||||||
008 111004s2012 njuad ob 001 0 eng d
005 20240125144853.0
020 |a 9781118266755 
020 |a 9781118266793  |q (e-book) 
020 |a 111826679X  |q (e-book) 
020 |a 1118266757  |q (electronic bk.) 
020 |a 9781118265895 
020 |a 1118265890 
020 |a 0470487534  |q (hbk.) 
020 |a 9780470487532 
020 |a 9786613621313 
020 |a 6613621315 
020 |z 9780470487532  |q (cloth) 
035 |a (NhCcYBP)e80fa363d91f485b9a695405a0a7a4bb9781118266755 
035 |a 1wileyeba9781118266755 
037 |a 10.1002/9781118266755  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
037 |a 3DFCF16A-0556-4E88-9BD9-2DD2607838E2  |b OverDrive, Inc.  |n http://www.overdrive.com 
040 |a NhCcYBP  |b eng  |c NhCcYBP 
050 4 |a HD9666.5  |b .E45 2012eb 
060 4 |a QV 736 
082 0 4 |a 338.4/76153  |2 23 
100 1 |a Ellery, Tony. 
245 1 0 |a Pharmaceutical lifecycle management :  |b making the most of each and every brand /  |c Tony Ellery, Neal Hansen. 
260 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c ©2012. 
300 |a 1 online resource (xxii, 389 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
500 |a Wiley EBA  |5 TMurS 
505 0 |a pt. A. Lifecycle management business environment -- pt. B. Lifecycle management regulatory and legal environment -- pt. C. Patents and exclusivities -- pt. D. Developmental LCM -- pt. E. Commercial LCM -- pt. F. Biologics and biosimilars -- pt. G. The integrated brand LCM strategy and its implementation -- pt. H. Integrating LCM with portfolio management. 
520 |a A comprehensive guide to optimizing the lifecycle management of pharmaceutical brandsThe mounting challenges posed by cost containment policies and the prevalence of generic alternatives make optimizing the lifecycle management (LCM) of brand drugs essential for pharmaceutical companies looking to maximize the value of their products. Demonstrating how different measures can be combined to create winning strategies, Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand explores this increasingly important field to help readers understand what they can--and must--do to get. 
504 |a Includes bibliographical references and index. 
546 |a English. 
650 0 |a Pharmaceutical industry  |x Economic aspects. 
650 0 |a Drug approval  |x Economic aspects. 
650 1 2 |a Drug Industry  |x economics 
650 2 2 |a Drug Approval  |x economics 
650 2 2 |a Economics, Pharmaceutical  |x legislation & jurisprudence 
650 2 2 |a Marketing  |x methods 
650 2 2 |a Pharmaceutical Preparations  |x economics 
700 1 |a Hansen, Neal. 
730 0 |a WILEYEBA 
776 0 8 |i Print version:  |a Ellery, Tony.  |t Pharmaceutical lifecycle management.  |d Hoboken, N.J. : John Wiley & Sons, ©2012  |z 9780470487532  |w (DLC) 2011041435 
856 4 0 |u https://ezproxy.mtsu.edu/login?url=https://onlinelibrary.wiley.com/book/10.1002/9781118266755  |z CONNECT  |3 Wiley  |t 0 
949 |a ho0 
975 |p Wiley UBCM Online Book All Titles thru 2023 
976 |a 6006612 
998 |a wi  |d z 
999 f f |s 8b3820cc-5a14-4e24-b619-a4964685ee1d  |i 8b3820cc-5a14-4e24-b619-a4964685ee1d  |t 0 
952 f f |a Middle Tennessee State University  |b Main  |c James E. Walker Library  |d Electronic Resources  |t 0  |e HD9666.5 .E45 2012eb  |h Library of Congress classification